SEC Company Response from CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) (CAPR) — Nov 17, 2006
CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)
Date: Nov. 17, 2006 · CIK: 0001133869 · Accession: 0001144204-06-048686
AI Filing Summary & Sentiment
Referenced dates: November 9, 2006
Show Raw Text
CORRESP
1
filename1.htm
SMI
Products, Inc.
122
Ocean
Park Blvd.
Suite
307
Santa
Monica, CA 90405.
Tel.
(310) 396-1691
November
9, 2006.
By
EDGAR Transmission and by Hand Delivery
Raquel
Howard
Staff
Accountant
U.S.
Securities and Exchange Commission.
100
F
Street N.E.
Washington,
D.C. 20549.
Re:
SMI Products, Inc.
Item
4.01 Form 8-K
Filed
November 8, 2006
File
No. 3-55166
Ladies
and Gentlemen:
On
behalf
of SMI Products, Inc. (the “Company”), we hereby submit the Company’s responses
to the comments of the staff (the “Staff”) of the Securities and Exchange
Commission (the Commission) set forth in the Staff’s letter, dated November 9,
2006, providing the Staff’s comments with respect to the above referenced Form
8-K Current Report (the “Report”).
For
the
convenience of the Staff, each of the Staff’s comments is included and is
followed by the corresponding response of the Company. References in this letter
to “we”, “us” and “our” refer to the Company unless the context indicates
otherwise.
1.
We
note your disclosure that you will discontinue the services of Amisano
Hanson
Chartered Accountants. This statement appears inconsistent with your
disclosure
that you have dismissed your former accountant. Please revise your
disclosure
to clarify your statement and disclose the specific date the former
accountant
was dismissed as required by Item 304(a)(1)(i) of Regulation
S-B.
COMPANY
RESPONSE.
We have
revised our disclosure to consistently state that Amisano Hanson was dismissed
and we have stated that such dismissal took place on October 31,
2006.
2.
We
note that that the former accountant audited your financial statements
for
the two
most recent fiscal years ended December 31, 2005 and 2004. Please revise
your
disclosure to address whether the former accountant's reports on your
financial
statements for either
of
the past two years contained an adverse opinion or disclaimer of opinion,
or were modified as to uncertainty, audit scope, or accounting
principles, which would include the uncertainty regarding the ability
to
continue
as a
going
concern.
See Item 304(a)(1)(ii) of Regulation S-B.
U.S.
Securities and Exchange Commission
November
9, 2006
Page
2
COMPANY
RESPONSE.
We have
revised our disclosure to include the disclosures required by Item
304(a)(1)(ii) of Regulation S-B. We have also included the language from Amisano
Hanson’s Reports for the years ended December 31, 2004 and December 31, 2005
with respect to their “going concern” opinion.
3.
We
note that your disclosure under 4.01(b) refers to the year ended September
30, 2006,
rather than the year ended December 31, 2006. Please revise or
advise.
COMPANY
RESPONSE.
We have
amended our disclosure to state the “year ending December 31, 2006”.
4.
Please
obtain and file an Exhibit 16 letter from the former accountant stating
whether the former accountant agrees with your revised Item 304 of
Regulation S-B
disclosures, or to the extent to which the accountant does not
agree.
COMPANY
RESPONSE.
We have
filed as Exhibit 16 a letter from Amisano Hanson with respect to the revised
Item 304 disclosures
The
Company further acknowledges as follows:
·
the
Company is responsible for the adequacy and accuracy of the disclosure
in
the filing;
·
staff
comments or changes to disclosure in response to staff comments do
not
foreclose the Commission from taking any action with respect to the
filing; and
·
the
Company may not assert staff comments as a defense
in any proceeding
initiated by
the Commission or any person under the federal securities laws of the
United States,
If
you
would like to discuss any of the responses to the Staff’s comments or if you
would like to discuss any other matters, please contact Robert L. B. Diener
at
(310) 396-1691.
Sincerely,
SMI
PRODUCTS, INC.
By:
/s/ Geoffrey
Alison
Geoffrey Alison
Chief Executive Officer.
2